Obesity drug maker Novo Nordisk ousts CEO as competition weighs
Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...
Monday, June 23, 2025
Tag: obesity
Obesity drugmaker Novo Nordisk misses Q2 profit forecast By Reuters
LONDON (Reuters) - Novo Nordisk (NYSE:) on Wednesday posted second-quarter operating profit below expectations, raised its 2024 sales forecast but ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.